Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,130.00    80.00 (1.13%)
Bid:
7,110.00
Ask:
7,120.00
Spread: 10.00 (0.141%)
Market Cap: £9.56b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Trading Statement

29 Aug 2018 07:00

RNS Number : 0518Z
Diploma PLC
29 August 2018
 

 

DIPLOMA PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

 

FOR IMMEDIATE RELEASE

 

29 August 2018

 

 

DIPLOMA PLC

 

TRADING UPDATE

 

 

Diploma PLC, the international group of businesses supplying specialised technical products and services, is today issuing a Trading Update for the year ending 30 September 2018.

 

Trading Summary

The Group has continued to trade robustly in the second half of the year and remains on track to report results for the full year in line with expectations.

 

Reported Group revenues for the year ending 30 September 2018 are expected to increase by ca. 7%. The headwind from the appreciation of UK sterling against the previous year has eased in the second half and is expected to impact revenues by ca. 3%. The acquisitions completed during the last eighteen months are expected to contribute ca. 3%, net of a small disposal. On an underlying basis, after adjusting for the impact of acquisitions and currency effects, Group revenues for the year are expected to increase by ca. 7%.

 

In the Life Sciences Sector, reported revenues are expected to be ca. 6% ahead of the comparable period, with a strong contribution from Abacus dx, the Australian diagnostic business acquired in April last year. On an underlying basis, Life Sciences revenues are expected to increase ca. 4% reflecting the benefit of good growth from the introduction of a new supplier in the Healthcare business and despite some capital project delays. In the Seals Sector, reported revenues have continued to benefit from strong trading conditions in both North America and Europe and are expected to increase by ca. 6% (up 9% on an underlying basis). In North America underlying revenues are expected to increase by ca. 11% although this rate of growth eases against a strong comparative in the final quarter of the financial year. In International Seals, underlying revenues have strengthened further in the second half of the year and are expected to grow by ca. 6% with strong trading in the European businesses supported by improved trading in Russia and Australia. In the Controls Sector, reported revenues are expected to increase by ca. 7% (up 4% on an underlying basis) against a strong comparative last year and reflecting generally positive trading conditions in its major European markets.

 

The Group's operating margin remains in line with expectations and is likely to be similar to that reported in the first half of the year.

 

Acquisitions

As announced on 22 August 2018, the Group has acquired FS Cables, a UK supplier of specialist cable products, for an initial cash consideration of £17.0m. The pipeline of acquisition opportunities remains healthy. The Group has a robust balance sheet and a proven track record of strong cash generation which the Group continues to reinvest in acquiring new businesses to accelerate growth.

 

At 30 September 2018, the Group's net cash funds are expected to be ca. £30m and the Group retains access to a £60m revolving credit facility.

 

In June 2018, the North American Seals business disposed of its engine and transmission gasket business for net asset value of ca. £4.5m.

 

The Group's results for the year ending 30 September 2018 will be announced on Monday, 19 November 2018.

 

 

Notes:

 

1. This Trading Update, which is based upon unaudited management accounts, has been prepared solely to provide additional information to the shareholders of Diploma PLC. It should not be relied on by any other party, for other purposes. Certain statements made in this Statement are forward-looking statements. Such statements have been made by the Directors in good faith using information available up until the date that they approved this Statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2. A copy of this Statement, together with further information about Diploma PLC, may be viewed on its website at www.diplomaplc.com

 

 

Diploma PLC -

+44 (0)20 7549 5700

Nigel Lingwood, Group Finance Director

Tulchan Communications -

+44 (0)20 7353 4200

Martin Robinson

David Allchurch

 

 

 

NOTE TO EDITORS:

 

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

 

Diploma's businesses are focussed on supplying essential products and services which are funded by the customers' operating rather than their capital budgets, providing recurring income and stable revenue growth.

 

Our businesses then design their individual business models to closely meet the requirements of their customers, offering a blend of high quality customer service, deep technical support and value adding activities. By supplying essential solutions, not just products, we build strong long term relationships with our customers and suppliers, which support attractive and sustainable margins.

 

Finally we encourage an entrepreneurial culture in our businesses through our decentralised management structure. We want our managers to feel that they have the freedom to run their own businesses, while being able to draw on the support and resources of a larger group. These essential values ensure that decisions are made close to the customer and that the businesses are agile and responsive to changes in the market and the competitive environment.

 

The Group employs ca. 1,700 employees and its principal operating businesses are located in the UK, Northern Europe, North America and Australia.

 

Over the last ten years, the Group has grown adjusted earnings per share at an average of ca. 14% p.a. through a combination of underlying growth and acquisitions. Diploma is a member of the FTSE 250 with a market capitalisation of ca. £1.5bn.

 

 

Further information on Diploma PLC, together with a copy of this Announcement, is available at www.diplomaplc.com

 

LEI: 2138008OG17VYG8FGR19

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPGUCGRUPRGQR
Date   Source Headline
30th May 20237:00 amRNSAppointment of Non-Executive Director
22nd May 20233:30 pmRNSHolding(s) in Company
15th May 20237:00 amRNSHalf-year Report
3rd Apr 20237:00 amRNSTotal Voting Rights
27th Mar 202310:34 amRNSHolding(s) in Company
24th Mar 20234:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20232:34 pmRNSHolding(s) in Company
22nd Mar 20237:00 amRNSIssue of Shares and Total Voting Rights
22nd Mar 20237:00 amRNSDirector/PDMR Shareholding
20th Mar 20239:14 amRNSHolding(s) in Company
17th Mar 20236:00 pmRNSDiploma
17th Mar 20237:00 amRNSResult of Placing
16th Mar 20234:47 pmRNSRetail Offer
16th Mar 20234:46 pmRNSProposed Placing
16th Mar 20234:45 pmRNSAcquisition and M&A Pipeline Update
20th Feb 20239:35 amRNSHolding(s) in Company
9th Feb 20238:27 amRNSHolding(s) in Company
30th Jan 20232:53 pmRNSHolding(s) in Company
19th Jan 20237:00 amRNSDirector/PDMR Grant of LTIP Award
18th Jan 202311:13 amRNSResult of AGM
18th Jan 20237:00 amRNSTrading Statement
12th Dec 20227:00 amRNSAnnual Financial Report & Notice of AGM
9th Dec 202210:33 amRNSHolding(s) in Company - Replacement
8th Dec 20229:41 amRNSHolding(s) in Company
1st Dec 20227:00 amRNSTotal Voting Rights
29th Nov 20227:00 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSDirector/PDMR Shareholding
21st Nov 20228:28 amRNSHolding(s) in Company
21st Nov 20227:00 amRNSFinal Results
17th Nov 20227:00 amRNSISSUE OF SHARES AND TOTAL VOTING RIGHTS
12th Oct 20222:06 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSDirector/PDMR Shareholding
8th Sep 20227:30 amRNSDirectorate Change
31st Aug 20227:00 amRNSDirector/PDMR Shareholding
10th Aug 20227:00 amRNSDirectorate Change
21st Jul 20227:00 amRNSTrading Statement
20th May 20223:19 pmRNSHolding(s) in Company
16th May 20227:00 amRNSHalf-year Report
12th Apr 20227:00 amRNSTrading Statement
8th Mar 20229:36 amRNSHolding(s) in Company
19th Jan 20224:00 pmRNSResult of AGM
19th Jan 20227:00 amRNSTrading Statement
10th Jan 20227:00 amRNSAGM arrangements in light of COVID-19
21st Dec 20217:00 amRNSDirector/PDMR Shareholding
7th Dec 20217:00 amRNSAnnual Financial Report & Notice of AGM
1st Dec 20217:00 amRNSTotal Voting Rights
30th Nov 20217:00 amRNSDirector/PDMR Shareholding
30th Nov 20217:00 amRNSDirector/PDMR Shareholding
23rd Nov 20217:00 amRNSDirector/PDMR Shareholding
22nd Nov 20217:06 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.